Condition
Late Life Depression (LLD)
Total Trials
5
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Recruiting4
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07623135Phase 3Recruiting
Lumateperone for Late-Life Depression
NCT07676851Recruiting
Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression
NCT07657234Not ApplicableNot Yet RecruitingPrimary
tDCS for Late-Life Depression
NCT06854367Not ApplicableRecruitingPrimary
Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression
NCT02434393Recruiting
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
Showing all 5 trials